Navigation Links
Insmed Provides Update on Supply of IPLEX(TM)
Date:7/27/2009

RICHMOND, Va., July 27 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today announced that, effective immediately, the Company will cease the supply of IPLEX((TM)) to any new patients. In addition, the Company will not initiate further clinical trials with IPLEX((TM)) at this time. The Company has determined that its limited inventory on hand must be conserved for the treatment of existing patients.

Following the previously announced sale of Insmed's Boulder, Colorado manufacturing facility to Merck & Co., Inc. in March 2009, Insmed no longer has the capability to manufacture IPLEX((TM)), an extremely complicated drug to produce. Moreover, any agreement with a third party to undertake the manufacture of IPLEX((TM)), if it was economically feasible and could be arranged, would not result in production of additional quantities of IPLEX(TM) for at least 12 to 18 months.

There are approximately 70 patients who currently receive IPLEX(TM), 12 in the U.S. and the remainder around the rest of the world. Most of the patients receive IPLEX(TM) pursuant to a court-ordered Extended Access Program (EAP) for Amyotrophic Lateral Sclerosis (ALS) in Italy. The 12 U.S. patients are being treated for ALS under single patient Investigational New Drug applications approved by the U.S. Food and Drug Administration. The Company believes that it has sufficient IPLEX(TM) inventory to supply these patients for no more than 24 months.

The Company intends to analyze the on-going data collected for various indications, including myotonic muscular dystrophy and ALS, and assess the overall IPLEX(TM) development program, including possible IPLEX(TM) manufacturing options with third parties and possible future clinical trials. Initiation of the Phase II clinical trial fo
'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
2. Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
3. Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants
4. Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs
5. Insmed to Present at Upcoming Healthcare Conferences
6. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
7. President Obamas Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model
8. Study provides documentation that tumor stem-like cells exist in benign tumors
9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
10. International Isotopes Inc. Announces Results of the Annual Meeting and Provides an Update on its Depleted Uranium Processing and Fluorine Extraction Process Plant
11. Leading Los Angeles Clinic (laserandveinclinic.com) Provides Top Notch Aesthetic Laser Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... MA (PRWEB) , ... September 02, 2015 , ... ... get swamped with a large stream of mixed documents that include EOBs, payments, ... various documents, while extracting the data needed to reconcile their billing, with one ...
(Date:9/2/2015)... ... September 02, 2015 , ... Michael Elliot Media announces a crowdfunding campaign ... as the primary love interest in the film. The campaign is being called ... how and what we think,” Michael Elliot, an award-winning screenwriter and CEO of Michael ...
(Date:9/2/2015)... ... September 02, 2015 , ... Since 2011, DoMyOwnPestControl.com has been ... to help support childhood cancer research. On June 17, 2014, the owners of ... which is the fund-raising event DoMyOwnPestControl.com sponsors each year. The very next day ...
(Date:9/2/2015)... ... ... Every year at this time, students prepare to go back to school. ... the academic workload confronting them. They just don’t have the skills needed to do ... students how to study. , “Bankers bank. Salesmen sell. Teachers teach. The job of ...
(Date:9/2/2015)... IL (PRWEB) , ... September 02, 2015 , ... ... of patented products, announces Hand Free Pocket Cop, a safety invention that protects ... the US is worth $31 billion," says Scott Cooper, CEO and Creative Director ...
Breaking Medicine News(10 mins):Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 2Health News:5 Essential Study Tips Every Student Needs for Academic Success but Schools Do Not Teach 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 2Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 3Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 4Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 5Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 6Health News:What Should You Be Watching As You Walk Alone At Night - World Patent Marketing's Hand Free Pocket Cop Invention 7
... Many feel pressured to breast-feed and ill-informed about alternative, ... -- The lack of information and support for mothers ... at risk, say British researchers who reviewed 23 studies ... will receive some formula milk during their first year ...
... 14 Northeast Health Care Quality Foundation, one of the ... licensing agreement with Milliman Care Guidelines, LLC, A Milliman Company, ... and quality reviews in Maine, New Hampshire and Vermont, and ... , , Northeast Health Care Quality Foundation will ...
... 14 As the discussion regarding health care reform moves through ... statement from the Society for Adolescent Medicine (SAM) urges all parties ... , , Says Dr. Mary-Ann Shafer, ... needed for adults and for younger children will also help adolescents. ...
... ... , ... 14, 2009 -- Broadlane announced today that Temple University Health System, Inc. (TUHS) ... procurement services in a three-year exclusive agreement to help manage its approximate $150 million ...
... NEW YORK, July 14 Delcath Systems, Inc. (Nasdaq: ... the second quarter ended June 30, 2009 on Monday, July 27, 2009 ... Hobbs, the Company,s new President & CEO will ... at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss the ...
... , , ATLANTA, July 14 "Head lice ... Tommy Lambert, Founder and President of Headhunters Lice Removal Service. "However as big ... no help available. I knew we had to be a part of that ... not as easy as Lambert would have thought. "I did a lot of ...
Cached Medicine News:Health News:Bottle-Feeding Moms Ignored 2Health News:Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines(R) for Medicare, Medicaid Reviews 2Health News:Northeast Health Care Quality Foundation QIO Uses Milliman Care Guidelines(R) for Medicare, Medicaid Reviews 3Health News:New Policy Statement from Society for Adolescent Medicine Urges Inclusion of Adolescent and Young Adult Health Issues in All Health Care Reform Legislation 2Health News:New Policy Statement from Society for Adolescent Medicine Urges Inclusion of Adolescent and Young Adult Health Issues in All Health Care Reform Legislation 3Health News:Temple University Health System to Improve Supply Chain with Broadlane 2Health News:Temple University Health System to Improve Supply Chain with Broadlane 3Health News:Temple University Health System to Improve Supply Chain with Broadlane 4Health News:Temple University Health System to Improve Supply Chain with Broadlane 5Health News:Temple University Health System to Improve Supply Chain with Broadlane 6Health News:Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress 2Health News:Headhunters Lice Removal Service Has Lice in Atlanta on the Run 2
(Date:9/2/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... of Neurocrine Biosciences, will be presenting at the Baird ... . The live presentation takes place ... The presentation will be webcast and may be accessed ... Listeners are encouraged to visit the website ...
(Date:9/2/2015)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, announced today that the first patient ... clinical trial of AGT-181 in patients with attenuated ... AGT-181 is an investigational enzyme replacement therapy (ERT) ... severe form of MPS I, Hurler syndrome, is ...
(Date:9/2/2015)... DIEGO , Sept. 2, 2015  Aethlon Medical, Inc. ... , Chairman and CEO, will be presenting at the Rodman ... New York, NY at 9:35 a.m. ET on ... made available to the public via live audio webcast which ... Aethlon Medical,s corporate website at http://www.aethlonmedical.com . The webcast ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4
... Determine the Efficacy of LBH589 in ... Refractory Multiple Myeloma, NORWALK, Conn., Aug. 14 ... in a Phase II,study to determine the efficacy of ... multiple myeloma. LBH589 is an orally,administered deacetylase inhibitor developed ...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today ... of Cardiology Foundation and the American Heart,Association and ... that,"ranolazine may be safely administered for symptom relief ... indicated for the,treatment of chronic angina in patients ...
Cached Medicine Technology:Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 2Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor 3Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2
... basic portable system for pH and temperature ... obtained when used with a temperature probe ... and easy one- and two-point calibration with ... (pH 1.68, 4.00, 7.00, 10.01 and 12.45) ...
... 3 swing doors, 12 shelves. Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
... 2 slide doors, 8 shelves. Over-sized ... doors. Fluorescent interior lighting. Self-Contained System ... foot cord. Full One Year Warranty on ... Warranty on Compressor. Also available as ...
... Independent controls for Digital ... series stainless steel front. Anodized aluminum ends. ... series stainless steel floor. , Oversized ... to -30C , Positive seal self-closing ...
Medicine Products: